An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US
Aim: Evaluation of the Nativis Voyager® device in patients with recurrent glioblastoma (rGBM). Materials & methods: Voyager is a noninvasive, nonthermal, nonionizing and portable investigational device which delivers ultra-low radio frequency energy (ulRFE®) that uses a magnetic field to penetrate t...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2019-03-01
|
| Seria: | CNS Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.futuremedicine.com/doi/10.2217/cns-2018-0013 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|